Clinical Trials
8 trialsNCT05643248 2023-10-31
To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects
Nanexa AB
Phase EARLY_PHASE1 Completed
NCT02851056 2022-11-14
Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT00424242 2021-09-08
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Northwestern University
Phase EARLY_PHASE1 Completed
NCT04650724 2020-12-03
Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Completed
NCT01594242 2019-04-16
Autophagy Induction After Bortezomib for Myeloma
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT01286675 2019-03-01
Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Completed
NCT02117115 2015-06-11
GVHD
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT00314743 2013-05-24
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
Washington University School of Medicine
Phase EARLY_PHASE1 Completed